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SUMMARY
A novel SYBR® green-real time polymerase chain reaction (qPCR) was developed to detect two Bartonella species, B. henselae 
and B. clarridgeiae, directly from blood samples. The test was used in blood samples obtained from cats living in animal shelters in 
Southern Brazil. Results were compared with those obtained by conventional PCR targeting Bartonella spp. Among the 47 samples 
analyzed, eight were positive using the conventional PCR and 12 were positive using qPCR. Importantly, the new qPCR detected the 
presence of both B. henselae and B. clarridgeiae in two samples. The results show that the qPCR described here may be a reliable 
tool for the screening and differentiation of two important Bartonella species.
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INTRODUCTION
Bartonella spp. are emerging infectious zoonotic agents13,23 endemic 
in some South American countries19. Bartonella can infect humans as 
well as domestic and wild mammals2. There are more than 23 described 
species within this genus6,8, among which, 13 are related to human 
diseases15. The most commonly reported species are B. bacilliformis, B. 
quintana, B. henselae1 and B. clarridgeiae18.
The main vectors associated with human infections are fleas 
(Ctenocephalides felis), lice (Pediculus humanus), sandflies (Lutzomyia 
verrucarum, Lutzomyia peruensis)15 and ticks (Ixodes pacificus)10. The 
main animal reservoirs are cats, dogs and rodents15. The infection is 
generally more severe in immunocompromised hosts, but may also occur 
in healthy subjects15. Bartonella bacilliformis is an important cause of 
severe illness and death among immunocompetent adults and children19.
B. henselae and B. clarridgeiae are known as the causative agents 
of cat-scratch disease (CSD), which is characterized by chronic 
lymphadenopathy11. Furthermore, in some cases, these bacteria may result 
in Parinaud oculoglandular syndrome, encephalopathy, convulsions, 
endocarditis, hepatosplenomegaly, glomerulonephritis, pleurisy, 
mediastinal adenopathy, nodules in the head of the pancreas, bacillary 
angiomatosis, osteomyelitis, atypical pneumonia, mammary tumours, 
haemolyticanaemia and eosinophilic purpura7. 
More than 4,000 cases of CSD are registered each year in the 
United States, resulting in over 2,000 hospitalizations in the same 
period, with a rate of 0.77 to 0.88 / 100,000 hospitalizations, with 
55% of cases occurring in patients younger than 18 years old14. In the 
Netherlands, an estimated 2,000 cases occur per year with a rate of 12.5 
cases/100 thousand inhabitants3. In Asian countries, reports show that 
the seroprevalence of B. henselae among the cat population ranges from 
9.1% to 15.1% in Japan, 68% in the Philippines, 48% in Singapore and 
54% in Indonesia7.
Bartonella spp are difficult-to-culture bacteria, hampering laboratory 
diagnosis of these infections. Other diagnostic alternatives, such as 
Giemsa-stained blood smears4 and serology7, are available with limited 
sensitivity, which may further delay proper diagnosis. 
Giemsa stained blood smears can be useful in screening blood 
samples, however, the presence of artifacts might be a confusing factor24. 
Serology has only a retrospective value, suggesting that the patient might 
have been infected during some period of their life, and hence is also 
of limited value. To date, no gold standard method for the detection of 
Bartonella species is available9.
Molecular techniques are powerful tools that may be used to screen 
for the presence of these pathogens in clinical samples16. Conventional 
polymerase chain reaction (PCR) has been used for the detection of 
several Bartonella species, and most of those assays use gene targets 
located on the 16S rRNA gene5, ribCgene17, rpo B gene22, 16S-23S 
intergenic spacer region (ITS)20 and gltA gene21. However, real-time 
PCR is substituting conventional PCR in many laboratories as it is not 
only quicker but also more sensitive and specific than its predecessor12. 
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The aim of this study was to evaluate a SYBR® green qPCR assay to 
detect and identify the presence of two Bartonella species directly from 
feline blood samples. 
METHODS
Blood samples from 47 cats were collected during 2009 in two 
municipal animal shelters (Novo Hamburgo and São Leopoldo, south 
of Brazil), and have been described previously24. All procedures were 
performed under veterinary supervision and approved by the Animal 
Ethics Committee from Universidade Feevale, under the protocol number 
2.12.03.09.1391.
DNA was extracted from blood samples with the QIAmpDNA 
blood mini Kit (Qiagen). Two new primer pairs were especially 
designed from consensus genome regions obtained from the DNA 
Data Bank of Japan (DDBJ). Primers targeting fragments of the 
Citrate synthase gene were: one generic forward primer (BART-
LC-GEN-F: 5’ – ATGGGTTTTGGTCATCGAGT – 3’); one 
specie-specific reverse B. henselae primer (BART-LC-HEN-R: 5’ 
–AA ATCGACATTAGGGTAAAGTTTTT – 3’); and one specie-
specific reverse B. clarridgeiae primer (BART-LC-CLA-R: 5’- 
CAAGAAGTGGATCATCTTGG – 3’). Specificity of the assay was 
assessed by testing known positive samples (B. henselae, B. clarridgeiae 
and B. bacilliformis, confirmed by DNA sequencing24), and several other 
clinical and ATCC-derived bacterial species. No false-positive reaction 
was noted with these tests. Apart from that, the specificity of the assay was 
also confirmed by in silico analysis of the primers, which demonstrated 
no cross-reaction with other Bartonella species. All positive results were 
confirmed by DNA sequencing reaction to make sure that these are true 
positive results and no false-positive samples were present. The results 
were analyzed by the DNA Data Bank of Japan (DDBJ Blast).
The reaction mix contained 2 µL of extracted DNA, 10 pM each 
primer, 1µL of BSA, 10 µL of SYBR green qPCR Supermix (Invitrogen) 
for a final volume of 20 µL. The multiplex qPCR was performed using 
the LightCycler®1.5 Real-Time PCR System (Roche Diagnostics) 
under the following conditions: 96 ºC for two min (DNA denaturation), 
followed by 40 cycles of 96 ºC for two sec, 60 ºC for five sec and 72 ºC 
for eight sec. A melting curve analysis was performed at the end of 
the amplification cycles. Positive reactions were recognized by typical 
melting temperatures (Tm ~ 82 ºC). Since both species showed the same 
Tm, identification of the species among positive samples was performed 
by a second qPCR using species-specific primers (Singleplex) under the 
same conditions. 
RESULTS
The multiplex SYBR® green qPCR allowed the detection of 
Bartonella DNA in 25.5% (12/47) of the blood samples. In a previous 
study, conventional PCR analysis targeting Bartonella spp in the same 
blood specimens resulted in a detection rate of 17.02% (8/47)24. DNA 
sequencing analysis of the PCR products obtained by conventional 
PCR revealed the presence of only two Bartonella species among those 
samples, which consisted of B. henselae, present in 10.63% (5/47) of the 
samples, and B. clarridgeiae in 6.38% (3/47)24. When using the multiplex 
qPCR, additional positive samples were observed with B. henselae and B. 
clarridgeiae detected in 17.02% (8/47) and 12.76% (6/47) of the samples, 
respectively (Table 1). Moreover, this assay allowed us to observe these 
species co-infecting two samples, this was not previously detected using 
conventional PCR.
DISCUSSION
Using multiplex qPCR, an additional four positive samples were 
found, which may represent an increase in sensitivity in comparison with 
the conventional PCR method. Moreover, the whole technique, including 
DNA extraction, could be performed within 2-3 hours, without any need 
of subsequent DNA sequencing for species identification. Conventional 
PCR, targeting consensus regions of the Citrate synthase gene may not 
amplify all Bartonella species with the same efficiency, thus explaining 
the differences in sensitivities obtained by our qPCR assay. Moreover, the 
identification of the species in positive samples depends on subsequent 
DNA sequencing. The advantage of the conventional PCR followed by 
DNA sequencing analysis would be the opportunity to identify the other 
or newer species that might be present in the blood samples. In this case, 
in a direct comparison, using the new specific primers for the detection 
of the two species identified by DNA sequencing, the qPCR assay was 
able to detect 100% of these species.
An advantage for the qPCR is the possibility of identifying the most 
prevalent Bartonella species in cat’s blood samples without the need of 
subsequent DNA sequencing, which is laborious and, in our case, was 
not able to detect the presence of co-infection in two samples.
In conclusion, our results suggest that the multiplex SYBR® green 
qPCR may be a useful technique to detect and differentiate the two 
most common species of Bartonella directly from blood samples. With 
the lack of a defined gold standard method to detect the presence of 
different Bartonella species, there is a need for improved, clinically 
Table 1




1 B. c. B. c.
2 B. h. B. h.
3 B. c. Neg.
4 B. h. Neg.
5 B. h. Neg.
6 B. h. / B. c. Neg.
7 B. h. B. h.
8 B. c. B. c.
9 B. c. B. c.
10 B. h. B. h.
11 B. h. / B. c. B. h.
12 B. h. B. h.
13-47 Neg. by both methods
B.h. (Bartonella henselae), B.c. (Bartonella clarridgeiae), Neg. (Negative).
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useful methods9 for diagnosis of these infections, and the method 
developed here may be a useful diagnostic tool. Furthermore, compared 
with conventional PCR, the multiplex SYBR® green qPCR seems to be 
more sensitive; however, this hypothesis needs to be further investigated 
using a more robust number of specimens. The real time PCR described 
here is faster than conventional PCR and can be adapted to detect 
other Bartonella species if necessary. The species found here are those 
associated with CSD, which, therefore, may pose some risk to public 
health, mainly for HIV-positive individuals. 
RESUMO
PCR em Tempo Real (qPCR) multiplex utilizando SYBR® 
Green para a detecção e diferenciação de Bartonella henselae e 
Bartonella clarridgeiae em gatos
Um novo teste baseado na reação em cadeia da polimerase em tempo 
real (qPCR) com SYBR ® Green foi desenvolvido para detectar duas 
espécies de Bartonella, B. henselae e B. clarridgeiae, diretamente em 
amostras de sangue. Este teste foi utilizado em amostras de sangue obtidas 
de gatos que vivem em abrigos de animais do sul do Brasil. Os resultados 
foram comparados aos obtidos pelo PCR convencional utilizado para 
a detecção de Bartonella spp. Das 47 amostras analisadas, oito foram 
positivas no PCR convencional e 12 foram positivas para qPCR. A reação 
de qPCR, permitiu a detecção da presença simultânea de B. henselae e 
B. clarridgeiae em duas destas amostras. Os resultados mostram que a 
qPCR aqui descrita pode ser uma ferramenta confiável para a detecção 
e diferenciação de duas espécies importantes de Bartonella spp. 
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